Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma

Table 1 Multivariate analysis of prognostic factors in patients with stage IVA hepatocellular carcinoma

Variable	No. of patients	Risk ratio	95% CI	P value
Treatment
Tegafur/uracil	28	0.170	0.069-0.441	< 0.001
Control	20	1
Cirrhosis
Yes	43	2.592	0.541-12.423	NS (P = 0.235)
No	5	1
Sex
Men	35	0.751	0.289-1.955	NS (P = 0.557)
Women	13	1
Age
≥ 65	22	0.678	0.307-1.499	NS (P = 0.337)
< 65	26	1
AFP
≥ 100	23	1.741	0.724-4.188	NS (P = 0.216)
< 100	25	1
Serum bilirubin
≥ 2.0	18	0.573	0.211-1.557	NS (P = 0.275)
< 2.0	30	1
Serum albumin
≥ 3.0	28	1.290	0.525-3.171	NS (P = 0.579)
< 3.0	20	1
Tumor thrombus
Yes	20	3.516	0.927-8.661	NS (P = 0.062)
No	28	1
Okuda staging
I/II	42	0.368	0.099-1.370	NS (P = 0.136)
III	6	1

NS: Not significant.